Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ACET

Adicet Bio Inc

Jul 26 • 04:00PM ET

1.59

Dollar change +0.08
Percentage change 5.30	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF FESM IWC CNCR VTWV CHNA BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.95	Insider Own	19.57%	Shs Outstand	82.17M	Perf Week	28.23%
Market Cap	130.65M	Forward P/E	-	EPS next Y	-1.58	Insider Trans	63.48%	Shs Float	66.09M	Perf Month	18.66%
Income	-139.79M	PEG	-	EPS next Q	-0.36	Inst Own	75.36%	Short Float	8.08%	Perf Quarter	-12.15%
Sales	0.00M	P/S	-	EPS this Y	50.93%	Inst Trans	5.17%	Short Ratio	3.99	Perf Half Y	-35.63%
Book/sh	3.15	P/B	0.50	EPS next Y	2.49%	ROA	-46.75%	Short Interest	5.34M	Perf Year	-36.90%
Cash/sh	3.01	P/C	0.53	EPS next 5Y	29.10%	ROE	-53.25%	52W Range	1.05 - 3.77	Perf YTD	-15.87%
Dividend Est.	-	P/FCF	-	EPS past 5Y	19.75%	ROI	-50.74%	52W High	-57.82%	Beta	1.77
Dividend TTM	-	Quick Ratio	14.34	Sales past 5Y	342.10%	Gross Margin	-	52W Low	51.43%	ATR (14)	0.11
Dividend Ex-Date	-	Current Ratio	14.34	EPS Y/Y TTM	-16.93%	Oper. Margin	0.00%	RSI (14)	66.80	Volatility	10.46% 7.97%
Employees	143	Debt/Eq	0.08	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.44	Target Price	9.00
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	50.72%	Payout	-	Rel Volume	0.75	Prev Close	1.51
Sales Surprise	-	EPS Surprise	21.96%	Sales Q/Q	-	Earnings	May 14 AMC	Avg Volume	1.34M	Price	1.59
SMA20	26.49%	SMA50	16.31%	SMA200	-12.91%	Trades		Volume	1,006,461	Change	5.30%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-27-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-27-23	Downgrade	Guggenheim	Buy → Neutral
Jun-01-23	Downgrade	JP Morgan	Overweight → Neutral	$20 → $6
Sep-21-22	Initiated	JP Morgan	Overweight	$23
Mar-31-22	Initiated	SMBC Nikko	Outperform	$28
Mar-08-22	Initiated	Truist	Buy	$30
Mar-04-22	Initiated	Jefferies	Buy	$27
May-18-21	Initiated	BTIG Research	Buy	$34
Apr-23-21	Initiated	H.C. Wainwright	Buy	$27
Apr-14-21	Initiated	Canaccord Genuity	Buy	$28
Apr-08-21	Initiated	Guggenheim	Buy	$22
Nov-04-20	Initiated	B. Riley Securities	Buy	$30
Oct-27-20	Initiated	JMP Securities	Mkt Outperform	$30
Oct-16-20	Initiated	Wedbush	Outperform	$25

Show Previous Ratings

Jul-25-24 01:24AM	Why Is Adicet Bio, Inc. (ACET) a Good One-Dollar Stock to Buy According to Hedge Funds? (Insider Monkey)
Jul-09-24 09:52AM	Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag (Zacks)
07:34AM	Adicet Bio's ADI-270 receives FDA Fast Track Designation for kidney cancer treatment (Pharmaceutical Business Review)
Jul-08-24 07:00AM	Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma (Business Wire) +9.35%
Jun-28-24 05:00PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -9.70%
07:00AM	Loading…
Jun-24-24 07:00AM	Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma (Business Wire) +9.49%
Jun-21-24 11:10AM	Is Adicet Bio, Inc. (NASDAQ:ACET) the Best Halal Stock ? (Insider Monkey)
10:53AM	7 Best Halal Stocks To Buy Now (Debt Free) (Insider Monkey)
Jun-10-24 07:22PM	Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 (InvestorPlace)
Jun-05-24 07:00AM	Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis (Business Wire) +5.88%
May-31-24 05:41PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-29-24 07:00AM	Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference (Business Wire) -7.05%
May-14-24 09:54PM	ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024 (InvestorPlace) -7.64% +5.26%
04:01PM	Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates (Business Wire)
10:00AM	Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress (Business Wire)
07:00AM	Loading…
May-07-24 07:00AM	Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference (Business Wire)
Apr-30-24 05:10PM	Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.29%
Apr-22-24 04:30PM	Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting (Business Wire)
Apr-08-24 07:00AM	Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire)
Apr-04-24 08:38AM	Why Adicet Bio (ACET) Stock Might be a Great Pick (Zacks)
Apr-01-24 09:40AM	Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-28-24 05:19PM	Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-22-24 09:35AM	Adicet Bio (ACET) Loses -16.39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +7.35%
Mar-19-24 09:53PM	ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023 (InvestorPlace) +5.42%
04:10PM	Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress (Business Wire)
Mar-15-24 09:40AM	Are Medical Stocks Lagging Adicet Bio (ACET) This Year? (Zacks)
Mar-11-24 07:00AM	Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference (Business Wire)
Feb-29-24 07:46PM	Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-28-24 09:40AM	Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-12-24 09:40AM	Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year? (Zacks)
04:01PM	Loading…
Feb-05-24 04:01PM	Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference (Business Wire)
Jan-31-24 04:39PM	Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-30-24 12:51PM	Hedge Fund and Insider Trading News: Larry Robbins, Ray Dalio, Two Sigma Investments, Point72 Asset Management, Bluebell Capital Partners, Adicet Bio Inc (ACET), Netflix, Inc. (NFLX), and More (Insider Monkey)
Jan-25-24 04:01PM	Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares (Business Wire)
09:40AM	Has Adicet Bio (ACET) Outpaced Other Medical Stocks This Year? (Zacks)
Jan-22-24 11:43PM	Adicet Bio, Inc. Announces Pricing of Public Offering (Business Wire)
04:28PM	Adicet Bio, Inc. Announces Proposed Public Offering (Business Wire)
Jan-04-24 07:00AM	Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024 (Business Wire) +22.73%
Jan-03-24 04:01PM	Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook (Business Wire) -12.44%
Dec-29-23 04:50PM	Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +8.62% +6.35%
Dec-10-23 12:00PM	Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting (Business Wire)
Nov-08-23 04:10PM	Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates (Business Wire) -6.02%
Nov-07-23 07:00AM	Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference (Business Wire) -8.04%
Nov-02-23 09:00AM	Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting (Business Wire) +13.85%
Oct-31-23 06:25PM	Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-04-23 12:00PM	Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference (Business Wire)
Sep-29-23 05:24PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-27-23 09:00AM	Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting (Business Wire)
Aug-31-23 04:35PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +11.11%
Aug-12-23 08:16AM	Will Adicet Bio (NASDAQ:ACET) Spend Its Cash Wisely? (Simply Wall St.)
Aug-09-23 04:15PM	Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates (Business Wire) +11.90%
Aug-02-23 04:00PM	Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference (Business Wire)
Jul-31-23 04:50PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.24%
Jul-11-23 08:30AM	Adicet Announces Appointment of Katie Peng to the Board of Directors (Business Wire)
Jun-30-23 04:51PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.19% +12.35%
Jun-26-23 04:00PM	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire) -54.29%
Jun-01-23 07:00AM	Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference (Business Wire) -5.20%
May-31-23 04:53PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-18-23 06:00AM	Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting (Business Wire)
May-09-23 04:30PM	Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference (Business Wire)
04:10PM	Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates (Business Wire)
Apr-28-23 05:13PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-26-23 08:01PM	7 Biotech Stocks With Huge Return Potential for Long-Term Investors (InvestorPlace)
Apr-17-23 06:58AM	Adicet Bio, Inc.'s (NASDAQ:ACET) Price Is Out Of Tune With Revenues (Simply Wall St.) +9.45%
Apr-13-23 07:00AM	Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire) +9.68%
Apr-04-23 02:47PM	Down More Than 60%: Analysts Say Buy These 3 Beaten-Down Stocks Before They Rebound (TipRanks) -6.14%
Mar-31-23 04:31PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-15-23 04:01PM	Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress (Business Wire)
11:44AM	7 Biotech Stocks That Could Be the Next Big Thing (InvestorPlace)
Mar-09-23 07:00AM	Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit (Business Wire)
Mar-05-23 07:09AM	Adicet Bio (NASDAQ:ACET) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Feb-28-23 05:31PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-01-23 07:00AM	Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference (Business Wire)
Jan-31-23 08:40PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.29%
Dec-30-22 04:43PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-20-22 08:23AM	Shareholders in Adicet Bio (NASDAQ:ACET) have lost 49%, as stock drops 22% this past week (Simply Wall St.)
Dec-10-22 10:00AM	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
Dec-02-22 07:00AM	Adicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
Nov-30-22 08:08PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
04:00PM	Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit (Business Wire)
Nov-29-22 07:00AM	Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer (Business Wire) +6.41%
Nov-11-22 05:24AM	Adicet Bio Third Quarter 2022 Earnings: US$0.53 loss per share (vs US$0.44 loss in 3Q 2021) (Simply Wall St.)
Nov-08-22 04:10PM	Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Nov-07-22 08:00AM	Adicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire) +7.22%
Nov-03-22 09:00AM	Adicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire) +5.16%
Nov-01-22 07:00AM	Adicet Bio to Present at the 2022 Jefferies London Healthcare Conference (Business Wire)
Oct-31-22 06:58PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-23-22 08:39AM	Calculating The Intrinsic Value Of Adicet Bio, Inc. (NASDAQ:ACET) (Simply Wall St.)
Oct-05-22 08:00AM	Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire)
Sep-30-22 06:59PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.88% +5.77%
Sep-26-22 06:26AM	We're Hopeful That Adicet Bio (NASDAQ:ACET) Will Use Its Cash Wisely (Simply Wall St.)
Sep-07-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire) +8.42%
Aug-31-22 05:30PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-16-22 06:16AM	The Consensus EPS Estimates For Adicet Bio, Inc. (NASDAQ:ACET) Just Fell Dramatically (Simply Wall St.) -8.67%
Aug-10-22 07:00AM	Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Aug-01-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Jul-29-22 06:05PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-01-22 04:10PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.61%
Jun-21-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Jun-06-22 07:00AM	Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting (Business Wire) +6.61%

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of "off-the-shelf" gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kauffman Michael	Director	Jun 05 '24	Sale	1.43	5,900	8,437	5,900	Jun 07 04:05 PM
ORBIMED ADVISORS LLC	Director	Jan 25 '24	Buy	2.40	3,125,000	7,500,000	7,526,359	Jan 26 07:14 PM
GORDON CARL L	Director	Jan 25 '24	Buy	2.40	3,125,000	7,500,000	7,526,359	Jan 26 07:13 PM
Schor Chen	President & CEO	Oct 02 '23	Buy	1.33	5,500	7,340	43,469	Oct 02 08:16 PM
Schor Chen	President & CEO	Sep 29 '23	Sale	1.36	5,500	7,481	176,969	Oct 02 08:16 PM
Schor Chen	President & CEO	Sep 28 '23	Buy	1.42	5,500	7,810	182,469	Oct 02 08:16 PM
Schor Chen	President & CEO	Sep 28 '23	Sale	1.42	5,500	7,810	37,969	Oct 02 08:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACET

Adicet Bio Inc

Upgrade your FINVIZ experience